Electronic health records hold vast amounts of patient data — so much that clinicians often struggle to distill what truly matters at the point of care. One of the most promising aspects of AI is its ...

Affordable Care Act Sign, A red, white and blue highway sign with words Affordable Care Act and an arrow sign with sky background In exiting that business, one healthcare expert believes Cigna is ...

Disagreements between providers and payers have been moving into the courtroom over the past few weeks. The California ...

The Trump administration’s crackdown on fraud, waste and abuse continues, with the Department of Justice last week launching a new effort targeting healthcare fraud. Experts think the new strike force ...

On Wednesday, the Centers for Medicare & Medicaid Services implemented a six-month moratorium on new Medicare enrollment for hospices and home health agencies. The moratorium seeks to temporarily stop ...

Enhertu, a targeted cancer therapy from partners AstraZeneca and Daiichi Sankyo, may now be used as a first-line treatment for advanced cases of breast cancer, making it the first new approved ...

Anomaly Insights, an AI-powered payer intelligence company, announced Wednesday that it raised $17 million in funding. The company’s platform analyzes healthcare transactions to identify payer ...

Rosarium Health, a company enabling aging at home, has raised $6 million in seed funding and secured partnerships with several Medicaid and Medicare Advantage plans, the company shared with MedCity ...

IKS Health, a Dallas-based company that sells software to healthcare providers, acquired ARAI this week to deepen its agentic AI infrastructure and decrease its reliance on third-party AI models. The ...

Today’s healthcare leaders are largely being sold “AI-as-a-service”: SaaS products that solve a specific task and connect to other SaaS products, enhanced with AI, as a wave of startups pushes AI into ...

Biopharmaceutical companies are increasingly turning to China for promising drug candidates and Bristol Myers Squibb is joining in, striking up a wide-ranging alliance with Hengrui Pharma, one of the ...

The high cost of GLP-1s is causing some employers to reconsider their coverage, a new survey from the Business Group on Health found. The survey received responses from 105 self-funded employers. It ...